Search Results 361-370 of 18020 for progesterone

1. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

   ... progesterone-only pills \[e.g. desogestrel\]) NOTE: There is a potential for tazemetostat interference with hormonal contraception methods due to enzymatic ...

2. Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients

   ... progesterone-only or combined (estrogen- and progesterone-containing) hormonal contraception associated with inhibition of ovulation, intrauterine devices ...

3. A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

   ... progesterone receptor [PgR]) by immunohistochemistry (IHC). Estrogen receptor and PgR assays are considered positive if there are at least 1% positive tumor ...

4. Galactorrhea - Symptoms and causes - Mayo Clinic

   This type of milky nipple discharge happens to people who aren't breastfeeding. Find out more about what can cause it and how to treat it.

5. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

   These include intrauterine device, implantable progesterone device, progesterone intramuscular injection, oral contraceptive initiated at least one month ...

6. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   ... progesterone receptor [PR] =< 10%, human epidermal growth factor receptor-2 [HER2]-negative per American Society of Clinical Oncology [ASCO]/College of ...

7. A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

   Oral contraceptive (combined or progesterone only) in females when combined with a chemical or physical barrier method;; Double-barrier method (any ...

8. Publications - Pooja P. Advani, M.B.B.S., M.D. - Mayo Clinic

   The Estrogen Pathway: Estrogen Receptor-alpha, Progesterone Receptor, and Estrogen Receptor-beta Expression in Radical Cystectomy Urothelial Cell Carcinoma ...

9. Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) - Mayo Clinic

   Pathologically confirmed as triple negative, source documented, defined as both of the following. Estrogen Receptor (ER) and Progesterone Receptor (PgR) ...

10. Study Of Sacituzumab Govitecan-hziy And Pembrolizumab Versus Treatment Of Physician's Choice In Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery And Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) - Mayo Clinic

    * TNBC criteria for the study is defined as estrogen receptor (ER) and progesterone receptor (PR) ≤ 10%, human epidermal growth factor receptor 2 (HER2)- ...